Implementation Support Strategies for Disruptive Behaviors
(SKIPforPA Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests strategies to improve the use of a treatment for childhood disruptive behaviors and ADHD in pediatric primary care offices. The treatment, known as Doctor Office Collaborative Care (DOCC), has already shown positive results in managing these issues. The trial will compare different ways to implement DOCC, such as providing extra support to practice leaders or care teams, to determine the most effective approach. Caregivers of children aged 5-12 with noticeable behavior problems would be a good fit for this trial. As an unphased trial, this study offers a unique opportunity to contribute to innovative strategies that could enhance care for children with behavioral challenges.
Will I have to stop taking my current medications?
The trial information does not specify whether participants need to stop taking their current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that Doctor Office Collaborative Care (DOCC) safely manages childhood behavior issues and ADHD. Studies have found that DOCC results in a high number of children starting and completing treatment. Specifically, 99.4% of children began treatment, and 76.6% completed it, indicating the treatment's positive reception.
Moreover, DOCC has led to significant improvements in children's behavior and emotions, underscoring its effectiveness and safety. No major reports of negative side effects have emerged, making it a promising option for those considering participation in a clinical trial.12345Why are researchers excited about this trial?
Researchers are excited about these treatments because they aim to enhance the implementation of DOCC, an evidence-based approach for managing disruptive behavior and ADHD. Unlike typical treatments that may lack structured support post-training, these strategies provide targeted support for practice leadership (LEAD) and care teams (TEAM), potentially increasing effectiveness. By providing tailored implementation support, these treatments might improve how DOCC is adopted and sustained in clinical settings, leading to better patient outcomes.
What evidence suggests that this trial's treatments could be effective for managing disruptive behavior and ADHD?
Research has shown that the Doctor Office Collaborative Care (DOCC) model effectively manages childhood behavior problems and ADHD. Studies have found that children are more likely to start and complete treatment with DOCC compared to regular care—99.4% start with DOCC versus 54.2% with usual care, and 76.6% complete treatment with DOCC versus 11.6% with usual care. DOCC also reduces oppositional behaviors and improves symptoms of oppositional defiant disorder (ODD) and overall quality of life over time. This model involves both the child and parent in behavioral therapy, a proven method for addressing disruptive behavior issues. The consistent improvements in clinical outcomes demonstrate DOCC's effectiveness in these areas. In this trial, participants will receive DOCC with varying levels of implementation support, including standard implementation, TEAM implementation, LEAD implementation, or both TEAM and LEAD implementation, to assess the impact of these support strategies on the effectiveness of DOCC.12567
Who Is on the Research Team?
David J Kolko, PhD
Principal Investigator
University of Pittsburgh
Are You a Good Fit for This Trial?
This trial is for caregivers with a child aged 5-12 showing behavior problems, and staff at selected pediatric practices in PA. Staff roles include primary care providers, care managers, medical directors/senior leaders, and practice managers.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Training
Standard training in the DOCC evidence-based practice (EBP) for all practices
Implementation
Implementation of DOCC with various support strategies (TEAM, LEAD, or both) delivered via videoconference
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- DOCC: Evidence-based treatment for disruptive behavior and ADHD
- Implementation support strategies at the leadership level following standard implementation of DOCC
- TEAM: Implementation support strategies at the care team level following standard implementation of DOCC
Trial Overview
The study tests if extra support strategies for teams and leadership can improve the use of DOCC—an effective treatment program for childhood behavior issues and ADHD—in various pediatric offices.
How Is the Trial Designed?
4
Treatment groups
Experimental Treatment
Active Control
Practices in this arm will receive DOCC training and materials and one type of implementation support after the training: coaching/consultation for the provider care team (TEAM).
Practices in this arm will receive DOCC training and materials and both types of implementation support after the training: coaching/consultation for the provider care team (TEAM) and facilitation for practice leadership (LEAD).
Practices in this arm will receive DOCC training and materials and only one type of implementation support after the training: facilitation for practice leadership (LEAD).
Practices in this arm will receive DOCC materials/training and technical support, but will not receive care team coaching/consultation (TEAM) or practice leadership facilitation (LEAD) after the training phase.
DOCC: Evidence-based treatment for disruptive behavior and ADHD is already approved in United States for the following indications:
- Disruptive behavior
- Attention-deficit/hyperactivity disorder (ADHD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
Pennsylvania American Academy of Pediatrics
Collaborator
NYU Langone Health
Collaborator
University of Michigan
Collaborator
Pennsylvania Chapter American Academy of Pediatrics
Collaborator
National Institute of Mental Health (NIMH)
Collaborator
American Academy of Pediatrics
Collaborator
Drexel University
Collaborator
Published Research Related to This Trial
Citations
Collaborative Care Outcomes for Pediatric Behavioral ...
DOCC (versus EUC) was associated with higher rates of treatment initiation (99.4% vs 54.2%; P < .001) and completion (76.6% vs 11.6%, P < .001), improvement in ...
Doctor-Office Collaborative Care for Pediatric Behavioral ...
Improvements in clinical outcomes were found for both conditions, but DOCC showed significantly greater reductions in oppositionality, ...
Effectiveness of Collaborative Services in Primary Care for ...
Behavioral therapy that targets parent and child skills has shown to be the most effective treatment for DBP. This study will evaluate the effectiveness of a ...
Effects of Collaborative Care for Comorbid Attention Deficit ...
Point-in-time contrasts showed that DOCC cases showed significant improvement in ODD symptoms and quality of life at 12 months and at 18 months; DOCC cases only ...
Implementation Support Strategies for Disruptive Behaviors
The doctor-office collaborative care (DOCC) model was found to be effective for treating pediatric behavior problems and ADHD, showing improved clinical ...
NCT04946253 | SKIP for PA Study: Team and Leadership ...
The treatment investigators seek to deliver here is called Doctor Office Collaborative Care (DOCC), an evidence-based intervention for the management of child ...
Doctor-office collaborative care for pediatric behavioral ...
Results: Group comparisons found significant improvements for DOCC over EUC in service use and completion, behavioral and emotional problems, individualized ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.